Effects of itraconazole and rifampicin on the pharmacokinetics and safety of youkenafil, a novel phosphodiesterase type 5 inhibitor, in healthy Chinese subjects-Reference-Cited by-同舟云学术

Effects of itraconazole and rifampicin on the pharmacokinetics and safety of youkenafil, a novel phosphodiesterase type 5 inhibitor, in healthy Chinese subjects

Published:2022-08 Issue: Volume:175 Page:106213
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Wang Keli,Ding Juefang,Li Xianjing,Guo Wenjing,Zhu Xingyu,Su Yue,Sun Luning,Zhou Huan,Ding Li^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference30 articles.

1. Study of pharmacokinetic interaction of paroxetine and roxithromycin on bencycloquidium bromide in healthy subjects;Agbokponto;Eur. J. Pharmaceutic. Sci.,2015

2. Rifampin drastically reduces plasma concentrations and effects of oral midazolam;Backman;Clin. Pharmacol. Ther.,1996

3. Two birds with one stone: regular use of PDE5 inhibitors for treating male patients with erectile dysfunction and cardiovascular diseases;Cai;Cardiovasc. Drugs Ther.,2019

4. Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction;Dorsey;Expert Opin. Pharmacother.,2010

5. Approach to the prediction of the contribution of major cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage;Emoto;Xenobiotica,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of conventional and investigational phosphodiesterase 5 inhibitors for treating erectile dysfunction and other conditions;Expert Opinion on Investigational Drugs;2024-08-11

3. LC-MS/MS methods for simultaneous determination of youkenafil and its metabolite M1 in human seminal plasma and plasma: Application to evaluate the acute effect of youkenafil on semen quality and its pharmacokinetics in human;Journal of Chromatography B;2024-04